miR-708/LSD1 axis regulates the proliferation and invasion of breast cancer cells

Cancer Medicine

Volumn 5, Issue 4, 2016, Pages 684-692

  Ma, Lin ^a   Ma, Shan ^b   Zhao, Guimei ^c   Yang, Longqiu ^d   Zhang, Peng ^b   Yi, Qingting ^b   Cheng, Shuguang ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b The Center Hospital of Zaozhuang Mining Group   (China)

^c Vocational College of Zaozhuang   (China)

^d ZHENGZHOU UNIVERSITY   (China)

Author keywords

Breast cancer; Invasion; LSD1; MiR 708; Proliferation

Indexed keywords

MICRORNA; MICRORNA 708; MICRORNA LSD1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; HISTONE DEMETHYLASE; KDM1A PROTEIN, HUMAN; MESSENGER RNA; MIRN708 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER CELL; CANCER CONTROL; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE DUPLICATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MDA MB 231 CELL; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; BREAST TUMOR; FEMALE; GENETICS; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEMETHYLASES; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; RNA, MESSENGER;

EID: 85006219499     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.623     Document Type: Article

References (38)

1. Ferlay, J., I. Soerjomataram, R. Dikshit, et al. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer Suppl. 136:E359-E386.
2. Hu, J., C. Chen, Q. Liu, et al. 2015. The role of the miR-31/FIH1 pathway in TGF-beta-induced liver fibrosis. Clin. Sci. 129:305-317.
3. Lee, R. C., R. L. Feinbaum, and V. Ambros . 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854.
4. Liu, Q., G. Wang, Y. Chen, G. Li, D. Yang, and J. Kang . 2014. A miR-590/Acvr2a/Rad51b axis regulates DNA damage repair during mESC proliferation. Stem Cell Rep. 3:1103-1117.
5. Croce, C. M. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10:704-714.
6. Calin, G. A., and C. M. Croce . 2006. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 66:7390-7394.
7. Mulrane, L., S. F. McGee, W. M. Gallagher, and D. P. O'Connor . 2013. miRNA dysregulation in breast cancer. Cancer Res. 73:6554-6562.
8. Saini, S., S. Yamamura, S. Majid, et al. 2011. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res. 71:6208-6219.
9. Jang, J. S., H. S. Jeon, Z. Sun, et al. 2012. Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin. Cancer Res. 18:3658-3667.
10. Song, T., X. Zhang, L. Zhang, et al. 2013. miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2. J. Cancer Res. Clin. Oncol. 139:1189-1198.
11. Saini, S., S. Majid, V. Shahryari, et al. 2012. miRNA-708 control of CD44(+) prostate cancer-initiating cells. Cancer Res. 72:3618-3630.
12. Yang, J., J. Wei, Y. Wu, et al. 2015. Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer. Oncogenesis 4:e158.
13. Li, G., F. Yang, H. Xu, Z. Yue, X. Fang, and J. Liu . 2015. MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration. Biomed. Pharmacother. 73:154-159.
14. Shi, Y., F. Lan, C. Matson, et al. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-953.
15. Metzger, E., M. Wissmann, N. Yin, et al. 2005. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437:436-439.
16. Hayami, S., J. D. Kelly, H. S. Cho, et al. 2011. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int. J. Cancer Suppl. 128:574-586.
17. Bennani-Baiti, I. M. 2012. Integration of ERalpha-PELP1-HER2 signaling by LSD1 (KDM1A/AOF2) offers combinatorial therapeutic opportunities to circumventing hormone resistance in breast cancer. Breast Cancer Res. 14:112.
18. Derr, R. S., A. Q. van Hoesel, A. Benard, et al. 2014. High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients. BMC Cancer 14:604.
19. Li, Q., L. Shi, B. Gui, et al. 2011. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. Cancer Res. 71:6899-6908.
20. Nagasawa, S., A. S. Sedukhina, Y. Nakagawa, et al. 2015. LSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibition. PLoS ONE 10:e0118002.
21. Ombra, M. N., A. Di Santi, C. Abbondanza, A. Migliaccio, E. V. Avvedimento, and B. Perillo . 2013. Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA. Biochim. Biophys. Acta 1829:480-486.
22. Vasilatos, S. N., T. A. Katz, S. Oesterreich, Y. Wan, N. E. Davidson, and Y. Huang . 2013. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells. Carcinogenesis 34:1196-1207.
23. Wang, Y., H. Zhang, Y. Chen, et al. 2009. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138:660-672.
24. Wu, Y., Y. Wang, X. H. Yang, et al. 2013. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells. Cell Rep. 5:224-236.
25. Yu, S. E., and Y. K. Jang . 2012. The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells. Biochem. Biophys. Res. Commun. 427:336-342.
26. Zhu, Q., Y. Huang, L. J. Marton, P. M. Woster, N. E. Davidson, and R. A. Jr Casero . 2012. Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells. Amino Acids 42:887-898.
27. Mertens-Talcott, S. U., S. Chintharlapalli, X. Li, and S. Safe . 2007. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 67:11001-11011.
28. Yoneda, T., P. J. Williams, T. Hiraga, M. Niewolna, and R. Nishimura . 2001. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J. Bone Miner. Res. 16:1486-1495.
29. Guo, P., J. Lan, J. Ge, Q. Nie, Q. Mao, and Y. Qiu . 2013. miR-708 acts as a tumor suppressor in human glioblastoma cells. Oncol. Rep. 30:870-876.
30. Lei, S. L., H. Zhao, H. L. Yao, et al. 2014. Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells. Oncol. Lett. 8:1768-1774.
31. Ma, L., J. Teruya-Feldstein, and R. A. Weinberg . 2007. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682-688.
32. Frankel, L. B., N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A. H. Lund . 2008. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283:1026-1033.
33. Yan, L. X., X. F. Huang, Q. Shao, et al. 2008. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14:2348-2360.
34. Jiang, S. A., H. W. Zhang, M. H. Lu, et al. 2010. MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene. Cancer Res. 70:3119-3127.
35. Kovalchuk, O., J. Filkowski, J. Meservy, et al. 2008. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol. Cancer Ther. 7:2152-2159.
36. Bhaumik, D., G. K. Scott, S. Schokrpur, C. K. Patil, J. Campisi, and C. C. Benz . 2008. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27:5643-5647.
37. Zhao, J. J., J. Lin, H. Yang, et al. 2008. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J. Biol. Chem. 283:31079-31086.
38. Lim, S., A. Janzer, A. Becker, et al. 2010. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31:512-520.